...
首页> 外文期刊>International journal of hyperthermia: The official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group >Response to pulsed dose rate and low dose rate irradiation with and without mild hyperthermia using human breast carcinoma cell lines.
【24h】

Response to pulsed dose rate and low dose rate irradiation with and without mild hyperthermia using human breast carcinoma cell lines.

机译:使用人乳腺癌细胞系对有无轻度高热的脉冲剂量率和低剂量率辐射的反应。

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this study was to establish whether a pulsed dose rate (PDR) treatment of 1.5 Gy given every 3 h in combination with 41 degrees C mild hyperthermia or a continuous low dose rate (LDR) treatment with mild hyperthermia could radiosensitize two isogenic human breast carcinoma cell lines in comparison to pulsed dose rate or low dose rate irradiation alone. The radiation resistant cell line was derived from the parental cell line and was transfected to over-express DNA polymerase beta. The end-points assessed were the survival of the cells using the clonogenic assay, the amount of residual DSB(s) using the comet assay and gene expression of polymerase beta using RT-PCR. Results showed that the PDR and LDR treatments combined with mild hyperthermia caused significant radiosensitization when compared to PDR and LDR irradiation alone in terms of the clonogenic and comet assays with both cell lines. RT-PCR results showed that polymerase beta levels of expression were not elevated in response to these treatments, implying that this polymerase may not be involved in sub-lethal damage repair or thermal radiosensitization. These results suggest a potential clinical advantage when combining LDR or PDR with hyperthermia, since they indicate that hyperthermia is an effective radiosensitizer.
机译:这项研究的目的是确定每3小时给予一次1.5 Gy的脉冲剂量率(PDR)治疗并结合41摄氏度的轻度高温治疗或持续低剂量率(LDR)轻度热疗治疗是否可以使两个同基因人类放射致敏与单独的脉冲剂量率或低剂量率辐射相比。抗辐射细胞系衍生自亲本细胞系,并被转染以过度表达DNA聚合酶β。评估的终点是使用克隆形成测定法的细胞存活率,使用彗星测定法的残留DSB量以及使用RT-PCR的聚合酶β基因表达。结果表明,就两种细胞系的克隆形成和彗星测定而言,与单独使用PDR和LDR照射相比,PDR和LDR处理与轻度高温相结合会引起显着的放射增敏作用。 RT-PCR结果显示,响应这些处理,聚合酶β的表达水平并未升高,这表明该聚合酶可能不参与亚致死性损伤修复或热放射致敏作用。这些结果表明,将LDR或PDR与热疗结合使用具有潜在的临床优势,因为它们表明热疗是一种有效的放射增敏剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号